GB9921684D0 - Assays - Google Patents

Assays

Info

Publication number
GB9921684D0
GB9921684D0 GBGB9921684.8A GB9921684A GB9921684D0 GB 9921684 D0 GB9921684 D0 GB 9921684D0 GB 9921684 A GB9921684 A GB 9921684A GB 9921684 D0 GB9921684 D0 GB 9921684D0
Authority
GB
United Kingdom
Prior art keywords
assays
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB9921684.8A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Syngenta Ltd
Original Assignee
Zeneca Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zeneca Ltd filed Critical Zeneca Ltd
Priority to GBGB9921684.8A priority Critical patent/GB9921684D0/en
Publication of GB9921684D0 publication Critical patent/GB9921684D0/en
Priority to AU70290/00A priority patent/AU7029000A/en
Priority to PCT/GB2000/003495 priority patent/WO2001020327A1/en
Priority to JP2001523862A priority patent/JP2003509070A/en
Priority to EP00958878A priority patent/EP1218742A1/en
Ceased legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6842—Proteomic analysis of subsets of protein mixtures with reduced complexity, e.g. membrane proteins, phosphoproteins, organelle proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/66—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood sugars, e.g. galactose
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Diabetes (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Biophysics (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
GBGB9921684.8A 1999-09-15 1999-09-15 Assays Ceased GB9921684D0 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
GBGB9921684.8A GB9921684D0 (en) 1999-09-15 1999-09-15 Assays
AU70290/00A AU7029000A (en) 1999-09-15 2000-09-13 Spa in a screening method for modulators of glucokinase
PCT/GB2000/003495 WO2001020327A1 (en) 1999-09-15 2000-09-13 Spa in a screening method for modulators of glucokinase
JP2001523862A JP2003509070A (en) 1999-09-15 2000-09-13 Assay
EP00958878A EP1218742A1 (en) 1999-09-15 2000-09-13 Spa in a screening method for modulators of glucokinase

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9921684.8A GB9921684D0 (en) 1999-09-15 1999-09-15 Assays

Publications (1)

Publication Number Publication Date
GB9921684D0 true GB9921684D0 (en) 1999-11-17

Family

ID=10860872

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9921684.8A Ceased GB9921684D0 (en) 1999-09-15 1999-09-15 Assays

Country Status (5)

Country Link
EP (1) EP1218742A1 (en)
JP (1) JP2003509070A (en)
AU (1) AU7029000A (en)
GB (1) GB9921684D0 (en)
WO (1) WO2001020327A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0102299D0 (en) 2001-06-26 2001-06-26 Astrazeneca Ab Compounds
SE0102764D0 (en) 2001-08-17 2001-08-17 Astrazeneca Ab Compounds
GB0226931D0 (en) 2002-11-19 2002-12-24 Astrazeneca Ab Chemical compounds
EP1835928A2 (en) * 2004-12-22 2007-09-26 Rheoscience A/S Mas related g protein coupled receptors as drug targets
NZ566877A (en) 2005-09-29 2010-05-28 Sanofi Aventis Phenyl-1,2,4-oxadiazolone derivatives, processes for their preparation and their use as pharmaceuticals

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993021330A1 (en) * 1992-04-22 1993-10-28 Zymogenetics, Inc. Human glutamine:fructose-6-phosphate amino-transferase
WO1998020024A1 (en) * 1996-11-04 1998-05-14 Merck Frosst Canada & Co. Ligands for phosphatase binding assay

Also Published As

Publication number Publication date
JP2003509070A (en) 2003-03-11
EP1218742A1 (en) 2002-07-03
AU7029000A (en) 2001-04-17
WO2001020327A1 (en) 2001-03-22

Similar Documents

Publication Publication Date Title
GB9902971D0 (en) Assay
GB9808145D0 (en) Assay
GB0009360D0 (en) Compound assay
AU141040S (en) Pipette
EP1210978A4 (en) Pipetter
EP1216935A4 (en) Case
GB9919134D0 (en) Assay
GB9900159D0 (en) Assay
GB9927576D0 (en) Novel assay
GB9923208D0 (en) Assay
GB9921684D0 (en) Assays
GB9803156D0 (en) Assay
HUP0201661A2 (en) Assay
GB9809160D0 (en) Assay
GB9913556D0 (en) Assays
GB9923309D0 (en) Assay
GB9922527D0 (en) Assay
GB9917659D0 (en) Assay
GB9930067D0 (en) Assay
GB9929820D0 (en) Assay
GB9926384D0 (en) Assay
GB9923599D0 (en) Assay
GB9927351D0 (en) Assay
GB9915392D0 (en) Assay
GB9910100D0 (en) Assay

Legal Events

Date Code Title Description
COOA Change in applicant's name or ownership of the application
AT Applications terminated before publication under section 16(1)